Posterior capsule opacification

Ocular Disease: Mechanisms and Management

Volumn , Issue , 2010, Pages 238-242

  West Mays, Judith ^a   Sheardown, Heather ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882523666     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-2983-7.00031-0     Document Type: Chapter

References (56)

1. Kappelhof JP, Vrensen GF The pathology of after-cataract. A minireview. Acta Ophthalmol 1992, Suppl.:13-24.
2. Wormstone IM Posterior capsule opacification: a cell biological perspective. Exp Eye Res 2002, 74:337-347.
3. Pandey SK, Apple DJ, Werner L, et al. Posterior capsule opacification: a review of the aetiopathogenesis, experimental and clinical studies and factors for prevention. Ind J Ophthalmol 2004, 52:99-112.
4. Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol 1992, 37:73-116.
5. Saika S Relationship between posterior capsule opacification and intraocular lens biocompatibility. Prog Retin Eye Res 2004, 23:283-305.
6. Wormstone IM, Tamiya S, Anderson I, et al. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci 2002, 43:2301-2308.
7. Nishi O, Nishi K, Menapace R, et al. Capsular bending ring to prevent posterior capsule opacification: 2 year follow-up. J Cataract Refract Surg 2001, 27:1359-1365.
8. Chen H, Brook MA, Chen Y, et al. Surface properties of PEO-silicone composites: reducing protein adsorption. J Biomater Sci Polym Ed 2005, 16:531-548.
9. Wallentin N, Wickstrom K, Lundberg C Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci 1998, 39:1410-1418.
10. Wormstone IM, Liu CS, Rakic JM, et al. Human lens epithelial cell proliferation in a protein-free medium. Invest Ophthalmol Vis Sci 1997, 38:396-404.
11. Wong TT, Daniels JT, Crowston JG, et al. MMP inhibition prevents human lens epithelial cell migration and contraction of the lens capsule. Br J Ophthalmol 2004, 88:868-872.
12. Dwivedi DJ, Pino G, Banh A, et al. Matrix metalloproteinase inhibitors suppress transforming growth factor-beta-induced subcapsular cataract formation. Am J Pathol 2006, 168:69-79.
13. Duncan G, Wormstone IM, Liu CS, et al. Thapsigargin-coated intraocular lenses inhibit human lens cell growth. Nat Med 1997, 3:1026-1028.
14. Ageing: A Public Health Challenge. Fact sheet no. 135 1998, World Health Organization, World Health Organization, Geneva.
15. Blindness: Vision 2020 - The Global Initiative for the Elimination of Avoidable Blindness. Fact sheet no. 213 2000, World Health Organization, World Health Organization, Geneva.
16. Allen D Cataract surgery. Exp Rev Ophthalmol 2007, 2:213-225.
17. Bullimore MA, Bailey IL Foreword: clarifying cataract. Optom Vis Sci 1993, 70:867-868.
18. Schaumberg DA, Dana MR, Christen WG, et al. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology 1998, 105:1213-1221.
19. Allen D Cataract surgery. Exp Rev Ophthalmol 2007, 2:213-225.
20. Meacock WR, Spalton DJ, Boyce J, et al. The effect of posterior capsule opacification on visual function. Invest Ophthalmol Vis Sci 2003, 44:4665-4669.
21. Griep AE, Zhang P Lens cell proliferation. Development of the Ocular Lens 2004, 191-213. Cambridge University Press, New York. F.J. Lovicu, M.L. Robinson (Eds.).
22. Pandey SK, Wilson ME, Trivedi RH, et al. Pediatric cataract surgery and intraocular lens implantation: current techniques, complications, and management. Int Ophthalmol Clin 2001, 41:175-196.
23. Pandey SK, Ram J, Werner L, et al. Visual results and postoperative complications of capsular bag and ciliary sulcus fixation of posterior chamber intraocular lenses in children with traumatic cataracts. J Cataract Refract Surg 1999, 25:1576-1584.
24. Fine IH Cortical cleaving hydrodissection. J Cataract Refract Surg 1992, 18:508-512.
25. Nishi O, Nishi K Preventing posterior capsule opacification by creating a discontinuous sharp bend in the capsule. J Cataract Refract Surg 1999, 25:521-526.
26. Buehl W, Menapace R, Findl O, et al. Long-term effect of optic edge design in a silicone intraocular lens on posterior capsule opacification. Am J Ophthalmol 2007, 143:913-919.
27. Davison JA Positive and negative dysphotopsia in patients with acrylic intraocular lenses. J Cataract Refract Surg 2000, 26:1346-1355.
28. Findl O, Buehl W, Menapace R, et al. Long-term effect of sharp optic edges of a polymethyl methacrylate intraocular lens on posterior capsule opacification: a randomized trial. Ophthalmology 2005, 112:2004-2008.
29. Buehl W, Findl O, Menapace R, et al. Long-term effect of optic edge design in an acrylic intraocular lens on posterior capsule opacification. J Cataract Refract Surg 2005, 31:954-961.
30. Kugelberg M, Wejde G, Jayaram H, et al. Posterior capsule opacification after implantation of a hydrophilic or a hydrophobic acrylic intraocular lens: one-year follow-up. J Cataract Refract Surg 2006, 32:1627-1631.
31. Cheng JW, Wei RL, Cai JP, et al. Efficacy of different intraocular lens materials and optic edge designs in preventing posterior capsular opacification: a meta-analysis. Am J Ophthalmol 2007, 143:428-436.
32. Hayashi K, Hayashi H Posterior capsule opacification in the presence of an intraocular lens with a sharp versus rounded optic edge. Ophthalmology 2005, 112:1550-1556.
33. Sacu S, Findl O, Menapace R, et al. Influence of optic edge design, optic material, and haptic design on capsular bend configuration. J Cataract Refract Surg 2005, 31:1888-1894.
34. Miyata K, Kato S, Nejima R, et al. Influences of optic edge design on posterior capsule opacification and anterior capsule contraction. Acta Ophthalmol Scand 2007, 85:99-102.
35. Bozukova D, Pagnoulle C, De Pauw-Gillet MC, et al. Improved performances of intraocular lenses by poly(ethylene glycol) chemical coatings. Biomacromolecules 2007, 8:2379-2387.
36. Okajima Y, Saika S, Sawa M Effect of surface coating an acrylic intraocular lens with poly(2-methacryloyloxyethyl phosphorylcholine) polymer on lens epithelial cell line behavior. J Cataract Refract Surg 2006, 32:666-671.
37. Klenkler BJ, Griffith M, Becerril C, et al. EGF-grafted PDMS surfaces in artificial cornea applications. Biomaterials 2005, 26:7286-7296.
38. Patel AS, Schlueter DC, Karakelle M, et al. Switchable tackiness coating compositions for ophthalmic implants. United States patent 2002: 20020028330.
39. Pinchuk L. Injectable intraocular lens that minimizes posterior capsule opacification and methods and materials for realizing the same. United States patent 2007: 20070255404.
40. Cousins SW, McCabe MM, Danielpour D, et al. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991, 32:2201-2211.
41. Qing J, Zhang Y, Derynck R Structural and functional characterization of the transforming growth factor-beta-induced Smad3/c-Jun transcriptional cooperativity. J Biol Chem 2000, 275:38802-38812.
42. Dunker N Transforming growth factor beta mediated programmed cell death in tissue regeneration of the murine intestinal mucosa. Ann Anat 2003, 185:299-300.
43. 2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992, 76:338-341.
44. McDonnell PJ, Rowen SL, Glaser BM, et al. Posterior capsule opacification. An in vitro model. Arch Ophthalmol 1985, 103:1378-1381.
45. Gimbel HV, Neuhann T Development, advantages, and methods of the continuous circular capsulorhexis technique. J Cataract Refract Surg 1990, 16:31-37.
46. Nagamoto T, Bissen-Miyajima H A ring to support the capsular bag after continuous curvilinear capsulorhexis. J Cataract Refract Surg 1994, 20:417-420.
47. Nagamoto T, Hara E Lens epithelial cell migration onto the posterior capsule in vitro. J Cataract Refract Surg 1996, 22(Suppl. 1):841-846.
48. Saxby L, Rosen E, Boulton M Lens epithelial cell proliferation, migration, and metaplasia following capsulorhexis. Br J Ophthalmol 1998, 82:945-952.
49. Wunderlich K, Pech M, Eberle AN, et al. Expression of connective tissue growth factor (CTGF) mRNA in plaques of human anterior subcapsular cataracts and membranes of posterior capsule opacification. Curr Eye Res 2000, 21:627-636.
50. Lovicu FJ, McAvoy JW Growth factor regulation of lens development. Dev Biol 2005, 280:1-14.
51. Symonds JG, Lovicu FJ, Chamberlain CG Posterior capsule opacification-like changes in rat lens explants cultured with TGFbeta and FGF: effects of cell coverage and regional differences. Exp Eye Res 2006, 82:693-699.
52. Mansfield KJ, Cerra A, Chamberlain CG FGF-2 counteracts loss of TGFbeta affected cells from rat lens explants: implications for PCO (after cataract). Mol Vis 2004, 10:521-532.
53. West-Mays JAPG Matrix metalloproteinases as mediators of primary and secondary cataracts. Exp Rev Ophthalmol Future Drugs 2007, 2:931-938.
54. Pande M, Spalton DJ, Marshall J Continuous curvilinear capsulorhexis and intraocular lens biocompatibility. J Cataract Refract Surg 1996, 22:89-97.
55. Nishi O, Nishi K, Saitoh I, et al. Inhibition of migrating lens epithelial cells by sustained release of ethylenediaminetetraacetic acid. J Cataract Refract Surg 1996, 22(Suppl. 1):863-868.
56. Awasthi N, Wagner BJ Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification. Invest Ophthalmol Vis Sci 2006, 47:4482-4489.